This document is an excerpt from the EUR-Lex website
Document 62019TN0664
Case T-664/19: Action brought on 30 September 2019 – Allergan Holdings France v EUIPO – Dermavita (JUVEDERM ULTRA)
Case T-664/19: Action brought on 30 September 2019 – Allergan Holdings France v EUIPO – Dermavita (JUVEDERM ULTRA)
Case T-664/19: Action brought on 30 September 2019 – Allergan Holdings France v EUIPO – Dermavita (JUVEDERM ULTRA)
OJ C 383, 11.11.2019, p. 79–80
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
11.11.2019 |
EN |
Official Journal of the European Union |
C 383/79 |
Action brought on 30 September 2019 – Allergan Holdings France v EUIPO – Dermavita (JUVEDERM ULTRA)
(Case T-664/19)
(2019/C 383/88)
Language of the case: English
Parties
Applicant: Allergan Holdings France (Courbevoie, France) (represented by: J. Day, Solicitor)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Dermavita Co. Ltd (Beirut, Lebanon)
Details of the proceedings before EUIPO
Proprietor of the trade mark at issue: Applicant before the General Court
Trade mark at issue: European Union word mark JUVEDERM ULTRA – European Union trade mark No 6 295 638
Procedure before EUIPO: Cancellation proceedings
Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 18 July 2019 in Joined Cases R 1655/2018-4 and R 1723/2018-4
Form of order sought
The applicant claims that the Court should:
|
— |
annul the contested decision insofar as it revokes the EUTM No. 6295638 JUVEDERM ULTRA for the contested goods; |
|
— |
order EUIPO and Dermavita Co. Ltd. to bear their own costs and pay those of the applicant. |
Pleas in law
|
— |
Infringement of Articles 58(1) and 64(5) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |